Search for: "In re DANAHER CORPORATION SHAREHOLDER DERIVATIVE LITIGATION" Results 1 - 6 of 6
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Jun 2021, 6:10 am by John Jascob
Accordingly, the court granted the defendants’ motion to dismiss (In re Danaher Corporation Shareholder Derivative Litigation, June 28, 2021, McFadden, T.).A Delaware corporation with its principal offices in Washington, D.C., Danaher is a Fortune 500 company that manufactures and markets medical, industrial and commercial products, with activities in approximately 60 countries. [read post]
16 Feb 2021, 2:23 pm by Kevin LaCroix
2020 was an eventful year in the world of corporate and securities litigation. [read post]
3 Jan 2022, 12:39 pm by Kevin LaCroix
In addition to the securities lawsuits, there were also at least 14 SPAC-related derivative lawsuits filed in 2021; all of the derivative suits involved companies that were also hit with securities suits. [read post]
4 Jan 2021, 1:26 pm by Kevin LaCroix
If the merger objection lawsuits are disregarded, the litigation rate translates to about 4.7%, which although below the record-level litigation rates during the period 2017 -2019 is still well above the 1996-2018 annual litigation rate of 3.0%. [read post]
7 Sep 2020, 2:06 pm by Kevin LaCroix
All of the companies hit with derivative suits are also involved in parallel securities litigation involving substantially the same allegations. [read post]